Earnings History Data for Intec Parent (INDP) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Intec Parent

Indaptus Therapeutics approach is based on the hypothesis which efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals. Indaptus Therapeutics, formerly known as Intec Parent Inc., is based in NEW YORK.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-05-2022	PM	INDP	Intec Parent	20.00	-0.41	-0.39	0.00	Indaptus Therapeutics GAAP EPS of -$0.41 [5/12/2022 8:35 AM]	2.32	0.11 (4.98%)	2.28	0.07 (3.17%)	2.13 - 28.83	36,943	30,000	7,282
Indaptus Therapeutics GAAP EPS of -$0.41 [5/12/2022 8:35 AM] Indaptus Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-12-22 08:00AM]
21-03-2022	??	INDP	Indaptus Therapeutics, Inc.	31.79	N/A	-0.60	-2.92	Indaptus Therapeutics GAAP EPS of -$1.89 [3/21/2022 7:23 AM]	3.87	0.02 (0.52%)	0.0	0.0 (0.00%)	3.01 - 28.83	49,857	150,481	0
Indaptus Therapeutics GAAP EPS of -$1.89 [3/21/2022 7:23 AM] Indaptus Therapeutics Reports Fourth Quarter and Year End 2021 Financial Results and Provides Corporate Update [Mar-21-22 07:00AM]